18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sestrins are evolutionarily conserved mediators of exercise benefits

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Exercise is among the most effective interventions for age-associated mobility decline and metabolic dysregulation. Although long-term endurance exercise promotes insulin sensitivity and expands respiratory capacity, genetic components and pathways mediating the metabolic benefits of exercise have remained elusive. Here, we show that Sestrins, a family of evolutionarily conserved exercise-inducible proteins, are critical mediators of exercise benefits. In both fly and mouse models, genetic ablation of Sestrins prevents organisms from acquiring metabolic benefits of exercise and improving their endurance through training. Conversely, Sestrin upregulation mimics both molecular and physiological effects of exercise, suggesting that it could be a major effector of exercise metabolism. Among the various targets modulated by Sestrin in response to exercise, AKT and PGC1α are critical for the Sestrin effects in extending endurance. These results indicate that Sestrin is a key integrating factor that drives the benefits of chronic exercise to metabolism and physical endurance.

          Abstract

          Exercise improves metabolic health and physical condition, particularly important for health in aged individuals. Here, the authors identify that Sestrins, proteins induced by exercise, are key mediators of the metabolic adaptation to exercise and increase endurance through the AKT and PGC1a axes.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.

          Activation of AMP-activated kinase (AMPK) in skeletal muscle increases glucose uptake, fatty acid oxidation, and mitochondrial biogenesis by increasing gene expression in these pathways. However, the transcriptional components that are directly targeted by AMPK are still elusive. The peroxisome-proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) has emerged as a master regulator of mitochondrial biogenesis; furthermore, it has been shown that PGC-1alpha gene expression is induced by exercise and by chemical activation of AMPK in skeletal muscle. Using primary muscle cells and mice deficient in PGC-1alpha, we found that the effects of AMPK on gene expression of glucose transporter 4, mitochondrial genes, and PGC-1alpha itself are almost entirely dependent on the function of PGC-1alpha protein. Furthermore, AMPK phosphorylates PGC-1alpha directly both in vitro and in cells. These direct phosphorylations of the PGC-1alpha protein at threonine-177 and serine-538 are required for the PGC-1alpha-dependent induction of the PGC-1alpha promoter. These data indicate that AMPK phosphorylation of PGC-1alpha initiates many of the important gene regulatory functions of AMPK in skeletal muscle.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

            Transcriptional complexes that contain peroxisome-proliferator-activated receptor coactivator (PGC)-1alpha control mitochondrial oxidative function to maintain energy homeostasis in response to nutrient and hormonal signals. An important component in the energy and nutrient pathways is mammalian target of rapamycin (mTOR), a kinase that regulates cell growth, size and survival. However, it is unknown whether and how mTOR controls mitochondrial oxidative activities. Here we show that mTOR is necessary for the maintenance of mitochondrial oxidative function. In skeletal muscle tissues and cells, the mTOR inhibitor rapamycin decreased the gene expression of the mitochondrial transcriptional regulators PGC-1alpha, oestrogen-related receptor alpha and nuclear respiratory factors, resulting in a decrease in mitochondrial gene expression and oxygen consumption. Using computational genomics, we identified the transcription factor yin-yang 1 (YY1) as a common target of mTOR and PGC-1alpha. Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and raptor interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. We have therefore identified a mechanism by which a nutrient sensor (mTOR) balances energy metabolism by means of the transcriptional control of mitochondrial oxidative function. These results have important implications for our understanding of how these pathways might be altered in metabolic diseases and cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              AMPK and PPARdelta agonists are exercise mimetics.

              The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases. Although certain natural compounds, such as reseveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive. We therefore tested the effect of pathway-specific drugs on endurance capacities of mice in a treadmill running test. We found that PPARbeta/delta agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice. Because training activates AMPK and PGC1alpha, we then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement. Unexpectedly, even in sedentary mice, 4 weeks of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%. These results demonstrate that AMPK-PPARdelta pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.
                Bookmark

                Author and article information

                Contributors
                rwessell@med.wayne.edu
                leeju@umich.edu
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                13 January 2020
                13 January 2020
                2020
                : 11
                : 190
                Affiliations
                [1 ]ISNI 0000000086837370, GRID grid.214458.e, Department of Molecular & Integrative Physiology, , University of Michigan, ; Ann Arbor, MI 48109 USA
                [2 ]ISNI 0000 0001 1456 7807, GRID grid.254444.7, Department of Physiology, , Wayne State University School of Medicine, ; Detroit, MI 48201 USA
                [3 ]ISNI 0000 0001 2107 4242, GRID grid.266100.3, Department of Pharmacology, , University of California San Diego, ; La Jolla, CA 92093 USA
                [4 ]ISNI 0000 0001 0707 9039, GRID grid.412010.6, Present Address: Department of Biochemistry, College of Natural Sciences, , Kangwon National University, ; Chuncheon, Gangwon 24341 Republic of Korea
                [5 ]ISNI 0000 0004 1937 0060, GRID grid.24434.35, Present Address: Department of Biochemistry, , University of Nebraska, ; Lincoln, NE 68588 USA
                Author information
                http://orcid.org/0000-0002-3144-5235
                http://orcid.org/0000-0002-9909-9279
                http://orcid.org/0000-0002-0922-0910
                http://orcid.org/0000-0002-2200-6011
                Article
                13442
                10.1038/s41467-019-13442-5
                6955242
                31929512
                7760ef2d-8011-4ae1-bbb6-e12ff2b10880
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 February 2019
                : 6 November 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100011232, U-M | MCubed, University of Michigan (Mcubed, U-M);
                Funded by: FundRef https://doi.org/10.13039/100000002, U.S. Department of Health & Human Services | National Institutes of Health (NIH);
                Award ID: K01AG061236
                Award ID: T32GM008322, T32AG000114 and F31DK117610
                Award ID: R21AG055712 and R01AG059683
                Award ID: R21AG045432, R01DK114131, R01DK11146, R01DK102850
                Award Recipient :
                Funded by: U.S. Department of Health & Human Services | National Institutes of Health (NIH)
                Funded by: FundRef https://doi.org/10.13039/100009160, Lawrence Ellison Foundation;
                Award ID: AG-SS-2440-10
                Award ID: AG-NS-0932-12
                Award Recipient :
                Funded by: U.S. Department of Health & Human Services | National Institutes of Health (NIH)
                Funded by: U.S. Department of Health & Human Services | National Institutes of Health (NIH)
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                metabolism,energy metabolism,molecular medicine
                Uncategorized
                metabolism, energy metabolism, molecular medicine

                Comments

                Comment on this article